Odomzo
Chemical Name | sonidegib |
Dosage Form | Capsule (oral; 200 mg) |
Drug Class | Inhibitors |
System | Skin |
Company | Sun Pharma Global |
Approval Year | 2015 |
Indication
- To treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation therapy.